Anhui Fengyuan Pharmaceutical Co Ltd banner
A

Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153

Watchlist Manager
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
Watchlist
Price: 6.55 CNY -0.46% Market Closed
Market Cap: ¥3B

Relative Value

The Relative Value of one Anhui Fengyuan Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 6.55 CNY, Anhui Fengyuan Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Anhui Fengyuan Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Anhui Fengyuan Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
3B CNY 0.7 26.7 23.3 23.3
US
Eli Lilly and Co
NYSE:LLY
961.6B USD 14.8 46.6 31.4 33.4
US
Johnson & Johnson
NYSE:JNJ
588.7B USD 6.2 22 15.2 18.7
CH
Roche Holding AG
SIX:ROG
292.6B CHF 4.8 31.2 13.1 15.3
UK
AstraZeneca PLC
LSE:AZN
236.9B GBP 5.5 31.8 17.5 24.7
CH
Novartis AG
SIX:NOVN
244B CHF 5.6 22.4 13.8 17.7
US
Merck & Co Inc
NYSE:MRK
301.6B USD 4.6 16.5 10.3 12.1
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.4 9.8 11.5
US
Pfizer Inc
NYSE:PFE
155.7B USD 2.5 20 7.5 10
UK
GSK plc
XETRA:GS71
105.9B EUR 2.8 16.1 8.1 11.5
P/E Multiple
Earnings Growth PEG
CN
A
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
Average P/E: 24.7
26.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.6
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22
7%
3.1
CH
Roche Holding AG
SIX:ROG
31.2
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.8
26%
1.2
CH
Novartis AG
SIX:NOVN
22.4
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.5
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
7%
1.9
US
Pfizer Inc
NYSE:PFE
20
26%
0.8
UK
GSK plc
XETRA:GS71
16.1
18%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
A
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
Average EV/EBITDA: 43.9
23.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
31.4
18%
1.7
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
13.1
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.5
11%
1.6
CH
Novartis AG
SIX:NOVN
13.8
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.3
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.8
7%
1.4
US
Pfizer Inc
NYSE:PFE
7.5
-4%
N/A
UK
GSK plc
XETRA:GS71
8.1
2%
4.1